Condition: Bariatric Surgery · Bone Health · Obesity, Morbid · Sponsor: CHU de Quebec-Universite Laval
Background: Bone fragility is a complication of type 2 diabetes. Diabetes treatments may ameliorate or deteriorate bone fragility in this population. Bariatric surgery is gaining in popularity in people with type 2 diabetes and may impact bone health. Objectives: To evaluate the impact of the most popular bariatric procedure worldwide (sleeve gastrectomy (SG)) on vBMD by QCT in patients with type 2 diabetes; Secondary aims: (1) to identify the determinants of vBMD after bariatric surgery in patients with type 2 diabetes; (2) to compare vBMD and its potential determinants after bariatric surgery with obese controls without diabetes as well as with controls without obesity and normoglycemia.
This description comes directly from the study's public registry record.
Sarah Chouinard-Castonguay · 4185254444 · Sarah.Chouinard-Castonguay@crchudequebec.ulaval.ca
Always discuss trial participation with your own doctor first.
| The Research Institute of the McGill University Health Centre | Montreal, Quebec, Canada | Terminated |
| Centre de recherche du CHU de Québec - Université Laval | Québec, Quebec, Canada | Active Not Recruiting |
| Centre de recherche de l'IUCPQ | Québec, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03455868